Direktor, BD Early Stage — CSL Behring
- Ort
- Bern
- Vertrag
- full-time
- Veröffentlicht
- Gestern
Rollenüberblick
The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
It provides deep subject-matter leadership and enterprise-level judgement to ensure potential partnerships and acquisitions advance CSL’s portfolio impact, scientific differentiation and competitive positioning.
- The Director, BD Early Stage leads the assessment of earl y- stage external innovation opportunities from Due Diligence Stage 2 to negotiation of a Non-Binding Offer ( NBO ) .
- The role integrates evolving scientific advances, therapeutic trends and market dynamics to guide CSL's long-range BD investment decisions in early - stage opportunities.
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Hauptaufgaben
- & Accountabilities External Innovation Evaluation Leadership:
- Lead evaluation of early-stage external assets, technologies, platforms and modalities aligned to TA Strategy from Due Diligence Stage 2 through Governance to negotiation of NBO.
- Integrate scientific, clinical, mechanistic, regulatory and commercial evidence into holistic assessments of attractiveness, differentiation and enterprise and TA strategic fit.
- Development of Investment-Ready Assessments:
- Deliver investment-quality inputs such as valuation assumptions, scenario modelling, unmet need assessments, deal analogues and downstream implications (e.g., biomarker requirements, specialized development pathways, manufacturing needs).
- Translate complex scientific and clinical narratives into clear, concise and decision-ready recommendations for CSL senior leaders.
- Strategic Judgement and Opportunity Prioritization:
- Provide recommendations on progressing, deferring or declining opportunities based on enterprise priorities and the TA Strategy.
Was das Unternehmen bietet
- CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
Bewerbungsprozess
- Cross-Functional Partnership and Collaboration:
- Develop and maintain key external partnerships with potential partners in close collaboration with R&D Search.
- Partner with BD Transactions to shape valuation logic, risk scenarios, deal structures and diligence readiness for advanced opportunities.
- Engage with global cross-functional partners including Commercial, Medical, Clinical Development, Regulatory, Technical Operations, Strategy, Finance to inform integrated and robust evaluation outputs.
- Governance and Decision Support:
- Prepare high-quality evaluation summaries, strategic assessments and decision papers for enterprise governance (e.g.
- PRISM, REDC) and other senior bodies as needed (e.g. PDCa, IDC)
- Ensure evaluation outputs reflect analytical depth, strategic clarity, scientific credibility and integrated cross-functional perspectives.
Unternehmen und Kontext
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS Education
- Bachelor’s degree in Life Sciences, Medicine, Pharmacy, Biology, Physiology or a related discipline (required) ;
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) . Experience
- 5-10+ years in pharmaceutical/biotech with substantive exposure to Search & Evaluation, early ‑ stage BD, R&D strategy or new product planning
- Proven ability to assess scientific/commercial potential and influence governance decisions
- Demonstrated success evaluating external opportunities, leading negotiations and influencing cross-functional and senior-level decisions
- Experience partnering across R&D, Commercial, Finance, Regulatory, and Transactions in a global matrix
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Weitere Details
- Responsibilities & Accountabilities External Innovation Evaluation Leadership:
- Apply CSL’s evaluation standards and prioritization frameworks to ensure rigor, consistency and balanced risk-benefit assessment.
- PRISM, REDC) and other senior bodies as needed (e.g.
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations. Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function. JOB SPECIFICATIONS
- Advanced degree such as PhD, MD, PharmD, MSc, MBA, or equivalent scientific/commercial qualification ( strongly preferred) .
- Proven ability supporting investment cases and contribute meaningfully to diligence and strategic evaluations
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I) High analytical capab
Notizen und Originalinhalt
- Responsibilities & Accountabilities
- External Innovation Evaluation Leadership:
- Support enterprise capital allocation and portfolio shaping discussions with clear strategic logic and evidence-driven recommendations.
- Team Leadership & Capability Development
- Strengthen organizational capability in scientific evaluation, market analysis, disease modelling and structured diligence within the BD function.
- JOB SPECIFICATIONS
- Experience
- Competencies
- Strong scientific literacy across modalities and early development (discovery/preclinical through Phase I)
- High analytical capab
Fragen zu dieser Stellenanzeige
Welches Gehalt bietet CSL Behring für diese Stelle?
CSL Behring gibt CHF 57'500 - 87'000 brutto pro Jahr für diese Position in Bern an. Dies ist das im Original-Inserat veröffentlichte Gehalt (oder, falls der Arbeitgeber keinen Betrag nennt, eine realistische Schätzung für Rolle und Branche) — der Rechner auf dieser Seite berechnet daraus Ihr tatsächliches Netto nach Grenzgänger-Steuer und Sozialabgaben.
Ist das eine Vollzeitstelle, und welchen Vertragstyp bietet CSL Behring?
Diese Stelle ist eine Vollzeit-Position. Der hier angezeigte Vertragstyp stammt direkt aus dem Original-Inserat des Arbeitgebers; klären Sie genaue Arbeitszeiten, Kündigungsfrist und Probezeit während des Bewerbungsprozesses mit CSL Behring, da diese Details auch innerhalb derselben Vertragskategorie variieren können.
Brauche ich eine Grenzgänger-Bewilligung für eine Stelle im Kanton Bern?
EU/EFTA-Bürger mit Wohnsitz in der Grenzzone des an den Kanton Bern angrenzenden Landes können eine G-Bewilligung beantragen; der Schweizer Arbeitgeber reicht sie nach Vertragsunterzeichnung beim Migrationsamt dieses Kantons ein. Grenzzonen-Regeln und Bearbeitungszeiten variieren je nach Nachbarland und Kanton — klären Sie die Details mit dem Migrationsamt des Kantons Bern oder mit HR während der Bewerbung.
Wie bewerbe ich mich für diese Stelle bei CSL Behring?
Nutzen Sie die Schaltfläche "Jetzt bewerben" auf dieser Seite — sie führt direkt zum Original-Inserat von CSL Behring unter csl.wd1.myworkdayjobs.com, sodass Ihre Bewerbung direkt im Bewerbermanagementsystem des Arbeitgebers landet. Frontaliere Ticino sammelt oder leitet keine Bewerbungen selbst weiter.
